LIFR and obesity disorder: The ability of EC359 to attenuate LIFR signaling in the presence of ADP-CM, as well as in co-culture systems with adipocytes, indicates its broad applicability of targeting LIFR in disrupting obesity-enhanced signaling pathways in TNBC.